title: Novel drug-eluting stents in the treatment of de novo coronary lesions.
abstract: Due to safety concerns in recent years, much effort has been devoted to improving the outcomes associated with drug-eluting stents (DESs). This review summarizes the current status of methodological and technical achievements reported in second-generation DES. Novel stents are described based on the component (the platform, the polymer, and the drug) that has undergone the most significant changes compared to earlier generation DES. An overview of the currently available evidence on the use of novel coronary devices in patients undergoing coronary revascularization is also reviewed.
authors.affiliation: Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy.
authors.forename: Davide
authors.initials: D
authors.lastname: Capodanno
authors.forename: Fabio
authors.initials: F
authors.lastname: Dipasqua
authors.forename: Corrado
authors.initials: C
authors.lastname: Tamburino
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D019317:Evidence-Based Medicine; D006801:Humans; D008670:Metals; D011108:Polymers; D011474:Prosthesis Design; D016896:Treatment Outcome
chemical_list: D008670:Metals; D011108:Polymers